Webinars offer a variety of presentations from worldwide experts in the field of Biosimilars.

Biosimilars in Nephrology

Jay Wish, MDJay Wish, MD
Professor of Clinical Medicine
Indiana University
Indianapolis, Indiana
 
 


Biosimilars on the Horizon in the US: A Review of What’s Coming and the European Experience

James G. Stevenson, PharmD, FASHPJames G. Stevenson, PharmD, FASHP
Professor
University of Michigan College of Pharmacy
President
Visante, Inc.
Ann Arbor, Michigan
 
 


Biosimilars: Payer and Formulary Considerations

Ross M. Miller, MD, MPH, FACPERoss M. Miller, MD, MPH, FACPE
Medical Advisor
California Department of Health Care Services
Los Angeles, California
 
 


Clinician and Payer Perspectives on the First Biosimilar Approved in the US

 

Gary H. Lyman, MD, MPHGary H. Lyman, MD, MPH
Co-Director
Hutchinson Institute for Cancer Outcomes Research
Professor of Medicine
University of Washington

 

Edmund J. Pezalla, MD, MPHEdmund J. Pezalla, MD, MPH
Vice President
Pharmaceutical Policy and Strategy
Aetna
Hartford, Connecticut


Comprehensive Review of Biosimilars vs. Reference Biologics

jonathan kayJonathan Kay, MD
Director of Clinical Research
Rheumatology Division
UMASS Memorial Medical Center
Professor of Medicine
University of Massachusetts Medical School
Worcester, Massachusetts
 


Interview: Expert Perspective on Biosimilars

Sanjiv S. Agarwala, MDSanjiv S. Agarwala, MD
Chief, Oncology & Hematology
St. Luke’s University Health Network
Professor of Medicine
Temple University
Philadelphia, Pennsylvania


The Fundamentals of Biosimilar Regulation and Development in the US

edward  liEdward Li, PharmD, MPH, BCOP
Associate Professor
University of New England College of Pharmacy
Portland, Maine
 


Access other Therapeutic Areas:


 

New & Noteworthy